Duopharma Biotech products on display. The company is among the mid-cap stocks favoured by UOB Kay Hian Malaysia Research.
KUALA LUMPUR: UOB Kay Hian Malaysia Research expects the stock market to move into a consolidation mode following a spectacular recovery into a bull territory from a global Covid-19 outbreak-induced bear market.
“We expect sentiment in 3Q20 to be affected by a poor economic recovery and consumption, sharply reduced retail investor participation, and internal political bickering, ” it said in its strategy outlook on Friday.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
